Anlotinib in patients with medullary thyroid carcinoma with negative prognostic factors: A sub-analysis based on the ALTER01031 study.
Zhao J, Chi Y, Hu C, Chen X, Ge M, Zhang Y, Guo Z, Wang J, Chen J, Zhang J, Cheng Y, Li Z, Liu H, Qin J, Zhu J, Cheng R, Xu Z, Li D, Tang P, Gao M, Zheng X.
Zhao J, et al. Among authors: liu h.
Front Oncol. 2022 Nov 22;12:852032. doi: 10.3389/fonc.2022.852032. eCollection 2022.
Front Oncol. 2022.
PMID: 36483043
Free PMC article.